TLSA Versus TBSA Surgical Approach for Hiatal Hernia With Gastroesophageal Reflux Disease
NCT07252115 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143
Last updated 2025-11-26
Summary
Gastroesophageal reflux disease (GERD), characterized by pathological reflux of gastric contents, affects 10%-20% of the global population with Western predominance and escalating incidence over recent decades. Anatomical and functional abnormalities of the esophagogastric junction (EGJ) such as hiatal hernia (HH) is one of the major pathophysiological mechanisms. GERD elevates risks for Barrett esophagus, esophageal adenocarcinoma and interstitial pulmonary fibrosis, while characteristic symptoms including reflux and heartburn substantially impair quality of life (QoL). Proton pump inhibitors (PPIs) are used to alleviate symptoms and prevent reflux-related esophageal mucosal damage, but may cause long-term adverse effects.
Anti-reflux surgery (ARS) is a well-established therapeutic option for patients with anatomical abnormalities, chronic PPI-refractory symptoms or unwilling to take lifelong PPIs. It provides comparable or potentially superior efficacy to PPIs, especially in reconstructing anatomical structures and addressing EGJ functional deficiencies. Maximize patients' QoL while minimizing side effects is priority for ARS. Despite advancements in surgical techniques, ARS remains invasive and is associated with inherent mechanical complications, including dysphagia and potential vagus nerve injury. A growing consensus recognizes that hepatic vagus nerve injury, occurring in a significant proportion of patients following ARS, potentially contributes to postoperative dysfunctions such as delayed gastric emptying, impaired reflux control, dyspeptic symptoms, cholelithiasis, ultimately diminishing QoL.
Although the traditional bilateral surgical approach (TBSA) is widely used, its requisite dissection of the lesser omentum invariably injures or severs the hepatic branch of the vagus nerve. The hepatic branch of the vagus arises from the anterior trunk and predominantly innervates the gastric antrum, pylorus, proximal duodenum and biliary tract. Functionally, it mediates a spectrum of vital physiological process including hepato-gastric reflexes that facilitate gastric motility via osmotic sensing, as well as glucose-sensitive reflexes that inhibit gastric motility and delay gastric emptying. Furthermore, hepatic branch is involved in food intake and metabolic homeostasis, and it exerts parasympathetic control over the coordinated contraction of the gallbladder and sphincter of Oddi. However, the functional preservation of the hepatic branch of the vagus nerve during ARS remains poorly understood, with limited clinical evidence and absent robust guidelines.
Based on our preliminary findings, we initiated a long-term evaluation of the total left-side approach (TLSA), a nerve-sparing strategy that preserves the lesser omentum and hepatogastric ligament to safeguard the hepatic branch of the vagus nerve, with the aim of enhancing postoperative QoL.
Conditions
- Hernia, Hiatal
- GERD (Gastroesophageal Reflux Disease)
Interventions
- PROCEDURE
-
Laparoscopic total left-sided surgical approach
The intervention group adopts the laparoscopic complete left-sided surgical approach.
- PROCEDURE
-
Laparoscopic traditional bilateral approach
The control group adopts the laparoscopic bilateral surgical approach.
Sponsors & Collaborators
-
Beijing Chao Yang Hospital
collaborator OTHER -
Xuanwu Hospital, Beijing
collaborator OTHER -
Beijing Friendship Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-04
- Primary Completion
- 2025-11-30
- Completion
- 2026-12-31
Countries
- China
Study Locations
More Related Trials
-
Prevalence of Hiatus Hernia in Gastro-Esophageal Reflux Disease Patients Underwent Upper Endoscopy
NCT06155851 ·Status: NOT_YET_RECRUITING
-
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
NCT01118585 ·Status: COMPLETED ·Phase: NA
-
Surgery in Chronic Cough GERD Related
NCT01899183 ·Status: COMPLETED
-
Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT06974903 ·Status: COMPLETED
-
GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery
NCT03143608 ·Status: COMPLETED
-
Manual Therapy and Gastroesophageal Reflux Disease in Patients With Hiatal Hernia
NCT05283447 ·Status: COMPLETED ·Phase: NA
-
Comparison of Treatment Outcome and Cost-effectiveness for GERD
NCT03661151 ·Status: UNKNOWN
-
Comparison of Total and Partial Fundoplication During Surgery of Patients With Gastroesophageal Reflux Disease
NCT03659487 ·Status: COMPLETED ·Phase: NA
-
Thresholds of Straight Leg Raise Maneuver During High-Resolution-Manometry
NCT04813029 ·Status: UNKNOWN ·Phase: NA
-
Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD)
NCT01110811 ·Status: COMPLETED ·Phase: NA
-
Stretta Versus Conservative Treatment
NCT05781347 ·Status: RECRUITING ·Phase: NA
-
A Study on the Effectiveness of Laparoscopic Fundoplication on Extraesophageal Manifestations of Gastroesophageal Reflux Disease (GERD)
NCT01324986 ·Status: COMPLETED ·Phase: NA
-
STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD
NCT02935881 ·Status: UNKNOWN ·Phase: PHASE3
-
the Efficency and Safety of Stretta in GERD
NCT03574831 ·Status: UNKNOWN
-
Effect of Fermented Soybean (FSB) Supplementation on Gas-troesophageal Reflux Disease (GERD)
NCT06524271 ·Status: COMPLETED ·Phase: NA
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
Stretta Treatment in GERD After SG
NCT05094895 ·Status: UNKNOWN ·Phase: NA
-
Observational Study of Anti-Reflux Surgery
NCT01624506 ·Status: COMPLETED
-
Impact of GERD on Daily Life (NIS)
NCT00545883 ·Status: COMPLETED
-
Anti-Reflux Mucosectomy in the Treatment of Refractory Gastro-esophageal Reflux
NCT05745012 ·Status: RECRUITING ·Phase: NA
-
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773 ·Status: COMPLETED
-
Heartburn, Gastroesophageal Reflux Disease
NCT07268820 ·Status: RECRUITING ·Phase: PHASE4
-
Endoloop Mediated Cardioplication to Treat Gastroesophageal Reflux Disease
NCT06153901 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD)
NCT03259191 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Diagnosis and Treatment Methods in Corrosive Esophagitis: A 26-Year Experience-Based Algorithm
NCT06816758 ·Status: COMPLETED